The analysis of apoptosis-related gene expression, including BAX, BCL2 and CASP3, also showed that the combined treatment did not have a greater effect on the expression of apoptosis genes in cancer cells compared to CAP and nZVI alone. This evidence concerns the gene BCL2 and cancer.